C

Celldex Therapeutics
D

CLDX

41.010
USD
0.92
(2.30%)
قبل الجلسة·40.250USD-0.760(-1.85%)
حجم التداول
8,944
الربح لكل سهم
-4
العائد الربحي
-
P/E
-9
حجم السوق
3,219,710,812
أصول ذات صلة المقالات
المزيد

العنوان: Celldex Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.